Andong Huang insider trades

Open-market stock purchases and sales by Andong Huang, Director at Outlook Therapeutics, Inc, from SEC Form 4 filings since Jun 19, 2020.

Recent trades

DateStockTradeValue
Oct 3, 2025OTLK Outlook Therapeutics, IncBought (not open market)—

Companies traded

  • OTLK Outlook Therapeutics, Inc: other filings, last Oct 3, 2025

Get free alerts when Andong Huang files a new trade →